Crossmark

Chitosan reduces inflammation and protects against oxidative stress in a hyperlipidemic rat model: relevance to nonalcoholic fatty liver disease

Published Online: 2022-08-04

Published Print: 2022-10

Authors

Kumar, Raushan

Arya, Jitendra Kumar

Rizvi, Syed Ibrahim https://orcid.org/0000-0001-8978-825X
Funding

Funding for this research was provided by:

Department of Biotechnology, Ministry of Science and Technology, India (Research Resources Services and Platforms)
License Information

Text and Data Mining valid from 2022-08-04

Version of Record valid from 2022-08-04
More Information

Article History

Received: 9 May 2022

Accepted: 19 July 2022

First Online: 4 August 2022

Delarations

:

: The authors of this manuscript have no conflict of interest.

: The study was carried out by the guideline given by the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals (PHS Policy) and the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Guide) as well as protocol approval approved by the Ethical Committee of the University of Allahabad, Allahabad.

Document is current